Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis
- Stephen T. Oh
- , Ruben A. Mesa
- , Claire N. Harrison
- , Prithviraj Bose
- , Aaron T. Gerds
- , Vikas Gupta
- , Bart L. Scott
- , Jean Jacques Kiladjian
- , Alessandro Lucchesi
- , Tim Kong
- , Sarah A. Buckley
- , Shanthakumar Tyavanagimatt
- , Bryan G. Harder
- , Karisse Roman-Torres
- , Jennifer Smith
- , Adam R. Craig
- , John Mascarenhas
- , Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review
63
Scopus
citations